中期肝癌的治疗现状  

Current treatment for intermediate-stage hepatocellular carcinoma

作　　者：尉文新[1] 雷正清 王葵[1] 沈锋[1] 

机构地区：[1]第二军医大学东方肝胆外科医院,上海200438

出　　处：《中华消化外科杂志》2016年第4期407-410,共4页Chinese Journal of Digestive Surgery

摘　　要：肝癌分期与其他实体肿瘤不同，需综合考虑肿瘤因素和肝脏的功能状态。目前有多个肝癌临床分期及顶后系统。中期肝癌常见于临床。但此期肝癌患者临床病理特征差异较大，治疗方法多样，治疗选择争议较多，疗效的异质性明显。笔者对中期肝癌的定义，治疗现状和再分期，尤其是肝切除术对中期肝癌患者的治疗价值作一综述，探讨提高中期肝癌个体化外科治疗的可行性。Staging of hepatocellular carcinoma （HCC） need to consider tumor factors and functional status of liver, which is different from other solid tumors. Now there are many clinical staging and prognosis systems of HCC. Intermediate stage HCC is commonly occurred at disease diagnosis, with varied clinicopathological charactertics, therapeutic options and survival outcomes of patients. In this review, the definition, cur- rent therapeutic strategies, substaging model of intermediate- stage HCC and the efficacy of liver resection for patients of inter- mediate-stage HCC are discussed for further improving feasibility of individualized surgical therapy.

关 键 词：肝肿瘤 中期 再分期 治疗 

分 类 号：R735.7[医药卫生—肿瘤]